ArticleClinical kidney journal2012
Survival over 2 years of autosomal-recessive renal tubular dysgenesis.
Article in Clinical kidney journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 12 citations in OpenAlex.
- ACE-related renal tubular dysgenesis (RTD-ACE) in a neonate surviving beyond the early neonatal period.Pediatric nephrology (Berlin, Germany) · 2026Article
- Long-term kidney function stabilization with fludrocortisone in autosomal recessive renal tubular dysgenesis: a case report.Pediatric nephrology (Berlin, Germany) · 2026Article
- Article
- Expanding the clinical spectrum of autosomal-recessive renal tubular dysgenesis: Two siblings with neonatal survival and review of the literature.Molecular genetics & genomic medicine · 2022Review
- Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor.Pediatric nephrology (Berlin, Germany) · 2021Article
- Renal Syndromic Hearing Loss Is Common in Childhood-onset Chronic Kidney Disease.Journal of Korean medical science · 2020Article
- A Premature Baby with Severe Oligohydramnios and Hypotension: a Case Report of Renal Tubular Dysgenesis.Journal of Korean medical science · 2020Article
- Bi-allelic mutations in renin-angiotensin system genes, associated with renal tubular dysgenesis, can also present as a progressive chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2020Article
- Successful treatment of severe arterial hypotension and anuria in a preterm infant with renal tubular dysgenesis- a case report.Maternal health, neonatology and perinatology · 2018Article
- Renal tubular dysgenesis.Pediatric nephrology (Berlin, Germany) · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autosomal-recessive renal tubular dysgenesis (AR-RTD) is a rare disorder caused by a genetic defect in the renin-angiotensin system. Although AR-RTD has typically been known as a lethal disease due to refractory hypotension and renal failure immediately after birth, few cases have reported survival of the neonatal period. We report here an additional case of AR-RTD, who had novel ACE mutations and survived over 2 years and provide a review of the five previously reported surviving cases. In conclusion, AR-RTD is not a uniformly fatal disease, although factors affecting the survival remain unknown.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.